Balyasny Asset Management LLC Tango Therapeutics, Inc. Transaction History
Balyasny Asset Management LLC
- $57.8 Billion
- Q1 2025
A detailed history of Balyasny Asset Management LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 3,219,571 shares of TNGX stock, worth $22.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,219,571
Previous 3,279,196
1.82%
Holding current value
$22.2 Million
Previous $10.1 Million
56.47%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
97.8MCall Options Held
1.1KPut Options Held
2.7K-
Trv Gp Iv, LLC Boston, MA16.9MShares$116 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$74.2 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$73.5 Million1.14% of portfolio
-
Nextech Invest Ag5.53MShares$38.2 Million3.19% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$38.2 Million1.76% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $609M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...